tiprankstipranks
Ryvu Therapeutics SA (DE:9Y4)
FRANKFURT:9Y4
Germany Market

Ryvu Therapeutics SA (9Y4) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
3Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
3Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Ryvu Therapeutics SA’s (9Y4) Moving Averages Convergence Divergence (MACD) indicator is 0.06, suggesting Ryvu Therapeutics SA is a Sell.
Ryvu Therapeutics SA’s (9Y4) 20-Day exponential moving average is 3.44, while Ryvu Therapeutics SA’s (9Y4) share price is €6.35, making it a Buy.
Ryvu Therapeutics SA’s (9Y4) 50-Day exponential moving average is 3.59, while Ryvu Therapeutics SA’s (9Y4) share price is €6.35, making it a Buy.

Ryvu Therapeutics SA (9Y4) Pivot Points

Aug 14, 2026, 08:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.48
3.48
3.48
3.48
3.48
3.48
3.48
Fibonacci
3.48
3.48
3.48
3.48
3.48
3.48
3.48
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ryvu Therapeutics SA (9Y4) Moving Averages

Aug 14, 2026, 08:01 AM
Period
Simple
Exponential
MA5
3.61Buy
3.61Buy
MA10
3.47Buy
3.52Buy
MA20
3.38Buy
3.44Buy
MA50
3.34Buy
3.59Buy
MA100
4.20Sell
4.08Sell
MA200
5.09Sell
4.85Sell
Ryvu Therapeutics SA’s (9Y4) 10-Day exponential moving average is 3.52, while Ryvu Therapeutics SA’s (9Y4) share price is €6.35, making it a Buy.
Ryvu Therapeutics SA’s (9Y4) 100-Day exponential moving average is 4.08, while Ryvu Therapeutics SA’s (9Y4) share price is €6.35, making it a Sell.
Ryvu Therapeutics SA’s (9Y4) stock price is €6.35 and Ryvu Therapeutics SA’s (9Y4) 50-day simple moving average is 3.34, creating a Buy signal.
Ryvu Therapeutics SA’s (9Y4) stock price is €6.35 and Ryvu Therapeutics SA’s (9Y4) 100-day simple moving average is 4.20, creating a Sell signal.
Ryvu Therapeutics SA’s (9Y4) stock price is €6.35 and Ryvu Therapeutics SA’s (9Y4) 200-day simple moving average is 5.09, creating a Sell signal.

Ryvu Therapeutics SA (9Y4) Technical Indicators

Aug 14, 2026, 08:01 AM
Name
Value
Implied Action
RSI (14)
64.95
Neutral
STOCH (9,6)
67.08
Neutral
STOCHRSI (14)
73.86
Neutral
MACD (12,26)
0.06
Sell
ADX (14)
13.50
Buy
CCI (14)
260.40
Sell
ATR (14)
0.11
-
Ultimate Oscillator
74.96
Buy
ROC
22.15
Buy
Bull/Bear Power (13)
0.75
Buy
Ryvu Therapeutics SA’s (9Y4) Relative Strength Index (RSI) is 64.95, creating a Neutral signal.
Ryvu Therapeutics SA’s (9Y4) Trend Strength Indicator (ADX) is 13.50, creating a Buy signal.
Ryvu Therapeutics SA’s (9Y4) Commodity Channel Index (CCI) is 260.40, creating a Sell signal.
Ryvu Therapeutics SA’s (9Y4) Price Rate of Change (ROC) is 22.15, creating a Buy signal.

FAQ

Is 9Y4 a Buy, Hold, or Sell?
Based on 9Y4’s technical indicators, 9Y4 is a Buy.
    What is 9Y4’s RSI (14)?
    9Y4’s RSI (14) is 64.95, which suggests 9Y4 is a Neutral.
      What is 9Y4’s MACD?
      9Y4’s MACD is 0.06, which suggests 9Y4 is a Sell.
        What is 9Y4’s 5-day moving average?
        9Y4’s 5-day moving average is 3.61, which suggests 9Y4 is a Buy.
          What is 9Y4’s 20-day moving average?
          9Y4 20-day moving average is 3.38, which suggests 9Y4 is a Buy.
            What is 9Y4’s 50-day moving average?
            9Y4’s 50-day moving average is 3.34, which suggests 9Y4 is a Buy.
              What is 9Y4’s 200-day moving average?
              9Y4’s 200-day moving average is 5.09, which suggests 9Y4 is a Sell.
                What is 9Y4’s Williams % R (14)?
                9Y4’s Williams % R (14) is 0.00, which suggests 9Y4 is a Buy.
                  What is 9Y4’s CCI (14)?
                  9Y4’s CCI (14) is 260.40, which suggests 9Y4 is a Sell.
                    What is the share price of Ryvu Therapeutics SA?